Traumatic Brain Injuries Assessment Market

Traumatic Brain Injuries Assessment Market Size

The global traumatic brain injuries assessment market size was valued at USD 2.3 billion in 2025. The market is expected to reach from USD 2.6 billion in 2026 to USD 4 billion in 2035, growing at a CAGR of 5.2% during the forecast period, according to the latest report published by Global Market Insights Inc. The high market growth is attributed to the rising incidence of road traffic accidents, growing sports-related and military-associated TBIs, and advancements in neuroimaging and diagnostic technologies, among other contributing factors.

Traumatic brain injuries (TBI) assessment is the detailed clinical, neurological, and diagnostic evaluation that establishes the occurrence, intensity, and the functional changes of brain injury after a physical blow to the head. It comprises neurological examinations, cognitive and behavioural assessments, imaging methods, and biomarker analysis to deliver prompt diagnosis, treatment planning, and prognosis.

The leading companies in the global traumatic brain injuries assessment market are PHILIPS, GE Healthcare, SIEMENS Healthineers, FUJIFILM, and RAUMEDIC. These companies maintain their competitive position through continuous product innovation, global market presence, and substantial investment in research and development.

The market has increased from USD 1.8 billion in 2022 and reached USD 2.1 billion in 2024, with the historic growth rate of 6.1%. The market growth was largely attributable to various factors such as the increasing number of road traffic accidents and sports-related injuries, the higher awareness and diagnosis of mild and moderate TBIs, the technological advancements in neuroimaging and point of care testing tools, and the widespread implementation of the standardized concussion assessment protocols in the departments of emergency and sports medicine.

Moreover, as urbanization intensifies and vehicle density rises, the prevalence of traumatic brain injuries (TBIs) has surged, largely due to a spike in road traffic accidents, workplace injuries, and fall-related incidents, particularly among the elderly. For instance, according to the World Health Organization (WHO), road traffic accidents accounted for approximately 1.2 million deaths globally in 2023, with a significant portion involving TBIs.

Additionally, the Centers for Disease Control and Prevention (CDC) reported that in 2022, falls were the leading cause of TBIs among older adults in the U.S., contributing to over 800,000 hospitalizations annually. This uptick underscores the growing demand for swift and precise assessment tools in emergency and trauma care.

Furthermore, technological progress in CT, MRI, EEG, and advanced biomarker-based diagnostics has improved the accuracy and speed of TBI assessment. These innovations enable earlier detection of mild and moderate TBIs that were previously underdiagnosed. Enhanced diagnostic confidence supports broader clinical adoption.

Traumatic Brain Injuries Assessment Market Trends

The market is growing considerably with the growing adoption of objective diagnostic tools, rising use of blood-based biomarkers for rapid screening, and integration of AI and advanced analytics in neuroimaging, among other factors collectively driving industry growth.

• There is a clear shift from symptom-based evaluations toward objective assessment tools such as imaging analytics, EEG, and biomarker tests. These technologies improve diagnostic accuracy and reduce variability in clinical decision-making. Objective tools are increasingly preferred in emergency and sports medicine settings.
  
• Healthcare providers are placing greater emphasis on identifying mild TBIs that often go undiagnosed. This trend is driven by awareness of long-term neurological impacts and rising sports-related injuries. It is fuelling demand for sensitive and portable assessment solutions.
  
• Moreover, clinicians are increasingly combining imaging, biomarkers, cognitive testing, and clinical scores for comprehensive TBI assessment. This multimodal approach improves diagnostic accuracy and patient stratification. It is becoming standard practice in complex trauma cases, thereby sustaining market growth.
  
  

Traumatic Brain Injuries Assessment Market Analysis

Learn more about the key segments shaping this market

Download Free PDF

The global market was valued at USD 1.8 billion in 2022. The market size reached USD 2.1 billion in 2024, from USD 1.9 billion in 2023.

Based on the product, the market is segmented into screening devices and monitoring devices. The screening devices segment has asserted its dominance in the market by securing a significant market share of 80.1% in 2025 owing to their rapid assessment capability, non-invasive nature, cost-effectiveness, and widespread adoption in emergency, sports, and pre-hospital settings for early detection and triage of traumatic brain injuries. The segment is expected to exceed USD 3.2 billion by 2035, growing at a CAGR of 5% during the forecast period.

On the other hand, the monitoring devices segment is expected to grow with a CAGR of 6.1%. The growth of this segment is driven by the increasing need for continuous neurological monitoring in critical care settings, rising adoption of advanced intracranial pressure and brain function monitoring technologies, and growing focus on early detection of secondary brain injuries to improve patient outcomes.

• The screening devices segment continues to dominate the market. Screening devices allow for rapid identification of suspected TBIs right at the point of care, which is invaluable in emergency and pre-hospital settings. Early detection gives clinicians the ability to prioritize patients and initiate interventions without delay. This strong demand for speed and efficiency is what mainly propels the adoption of these devices.
  
• Emergency medical services, ambulances, and urgent care centers increasingly rely on portable screening devices. These tools allow on-site evaluation before hospital admission. The shift toward decentralized care models is a major growth driver.
  
• The monitoring devices segment held a revenue of USD 465.1 million in 2025, with projections indicating a steady expansion at 6.1% CAGR from 2026 to 2035. The segment is driven by increasing adoption of long-term patient management protocols in intensive care units, growing use of data-driven clinical decision support for TBI management, and rising demand for real-time tracking of neurological status during post-injury recovery and rehabilitation.
  

Learn more about the key segments shaping this market

Download Free PDF

Based on end use, the traumatic brain injuries assessment market is classified into hospitals, diagnostic centers, and other end users. The hospitals segment dominated the market with a revenue share of 57.9% in 2025 and is expected to reach USD 2.4 billion within the forecast period.

• Hospitals are the primary point of care for patients with head injuries resulting from accidents, falls, and violence. Emergency departments require rapid and accurate TBI assessment to triage patients effectively. This high patient inflow drives continuous demand for advanced assessment tools.
  
• Moreover, the increased number of road traffic accidents and the rising trend of age-related falls are the two main factors that contribute to a large number of hospital admissions for suspected traumatic brain injuries (TBIs). Hospitals need to be prepared to handle any severe spectrum of the injuries. This epidemiological trend reinforces the need for comprehensive TBI assessment solutions.
  
• The diagnostic centers segment accounted for significant revenue in 2025 and is anticipated to grow at a CAGR of 4.9% over the forecast period. The segment expansion is led by a higher number of referrals for specialized neurodiagnostic evaluations, the increased outsourcing of advanced imaging and neurological tests by hospitals, and the growing preference for standalone centers that offer faster turnaround times and cost-efficient TBI assessments.
  

Looking for region specific data?

Download Free PDF

North America Traumatic Brain Injuries Assessment Market

North America dominated the global market with the highest market share of 40.1% in 2025.

• The U.S. market was valued at USD 716.8 million and USD 734.5 million in 2022 and 2023, respectively. The market size reached USD 881.6 million in 2025, growing from USD 790.9 million in 2024, and is anticipated to grow at a CAGR of 4.2% between 2026 to 2035.
  
• The main contributors to TBI occurrences in North America are the road traffic accidents, fall, related injuries among the elderly, and sports related concussions. Such a large injury burden significantly stresses the need for timely and accurate assessment tools. Advanced diagnostic solutions are in high demand in emergency departments.
  
• Moreover, the region has a well-established network of trauma centers, hospitals, and neurocritical care units. These facilities are equipped to adopt advanced imaging and screening technologies. Robust infrastructure supports rapid integration of new TBI assessment solutions.
  

Europe Traumatic Brain Injuries Assessment Market

Europe market accounted for USD 664.1 million in 2025 and is anticipated to show lucrative growth over the forecast period.

• European healthcare systems prioritize universal access and early-stage diagnosis to reduce long-term disability costs. Public hospitals are encouraged to assess suspected TBIs comprehensively at initial presentation. This policy-driven focus supports consistent demand for standardized TBI assessment tools across countries.
  
• Europe has one of the world’s fastest-ageing populations, particularly in Western and Southern Europe. Age-related falls are a leading cause of hospitalizations for head injuries. This demographic pressure drives adoption of reliable TBI assessment solutions in emergency and geriatric care settings.
  

Asia Pacific Traumatic Brain Injuries Assessment Market

The Asia Pacific market is anticipated to grow at the highest CAGR of 6.7% during the analysis timeframe.

• Implementation technologies for traumatic brain injury (TBI) are in high demand due to the rapid urbanization of Asia Pacific cities, which has increased construction activities, traffic density, and industrial operations. Consequently, there has been a rise in the number of people suffering from head injuries that require emergency assessment. Urban hospitals and trauma care facilities that are growing in size have become the source of this demand for TBI assessment technologies.
  
• Governments in countries such as India, China, Indonesia, and Vietnam are improving access to emergency and diagnostic care. Increased healthcare coverage and hospital penetration enable more patients to receive timely TBI assessment. This expansion is unlocking previously under-served patient populations.
  

Latin America Traumatic Brain Injuries Assessment Market

The Latin America market is experiencing robust growth over the analysis timeframe.

• Several Latin American countries report a relatively high incidence of interpersonal violence and assault-related trauma. Head injuries from such incidents frequently require emergency neurological evaluation. This epidemiological pattern drives sustained demand for hospital-based TBI assessment solutions.
  
• Expansion of private healthcare providers and employer-backed insurance plans is improving access to advanced diagnostics. Private hospitals often invest in modern assessment technologies to differentiate service quality. This trend supports adoption of advanced TBI assessment tools.
  

Middle East & Africa Traumatic Brain Injuries Assessment Market

The Middle East & Africa (MEA) market is experiencing robust growth over the analysis timeframe.

• The regional growth is driven by increasing conflict and disaster-related injuries, which create demand for rapid neurological evaluation in emergency settings. Growing investments in healthcare digitalization and telemedicine are enabling remote and faster assessment of brain injuries, particularly in underserved areas.
  
• Expansion of specialized trauma training programs for healthcare professionals is improving diagnosis rates and technology utilization. Additionally, rising public–private partnerships aimed at strengthening critical care capabilities are supporting adoption of advanced TBI assessment solutions across the region.
  
  

Traumatic Brain Injuries Assessment Market Share

The global market is characterized by the presence of a mix of global medical device giants, specialized diagnostic solution providers, and emerging players focusing on innovative technologies. Companies are increasingly emphasizing research and development to introduce advanced screening devices, AI-powered neuroimaging tools, and portable point-of-care solutions to enhance diagnostic accuracy and speed.

Key players include PHILIPS, GE Healthcare, SIEMENS Healthineers, FUJIFILM, and RAUMEDIC, collectively accounting for 45% of the total market share. Strategic collaborations, mergers, and acquisitions are common as companies aim to strengthen their product portfolios and expand geographic reach.

The market is also witnessing differentiation through product innovation, regulatory approvals, and tailored solutions for hospitals, sports medicine, military, and emergency care settings. Regional players in Europe, Asia Pacific, and MEA are gaining traction by offering cost-effective and portable TBI assessment solutions to meet local healthcare demands.

Companies are increasingly investing in digital platforms, AI integration, and biomarker-based technologies to maintain a competitive edge and address the growing need for rapid, accurate, and standardized TBI assessment globally.

Traumatic Brain Injuries Assessment Market Companies

A few of the prominent players operating in the traumatic brain injuries assessment industry include:

• BIOMERIEUX
• BrainScope
• COMPUMEDICS
• FUJIFILM
• GE Healthcare
• InfraScan
• INTEGRA
• Natus Medical
• NIHON KOHDEN
• Oculogica
• PHILIPS
• RAUMEDIC
• SIEMENS Healthineers
• ZOLL Medical
  
  
• PHILIPS

Philips offers integrated neuroimaging platforms paired with AI-driven analytics that enhance detection accuracy and streamline clinical workflows for TBI assessment. Its strong global service network and interoperability with healthcare IT systems improve adoption across acute and emergency care settings.

• GE Healthcare

GE Healthcare delivers high-resolution CT and MRI solutions with advanced software for precise visualization of brain injuries, supporting faster and more reliable diagnosis. Its robust digital health ecosystem and clinician training programs help deepen market penetration in hospitals and trauma centres.

• SIEMENS Healthineers

Siemens Healthineers provides cutting-edge imaging modalities with real-time quantitative analysis and sophisticated neuro assessment tools that improve early TBI detection and monitoring. The company’s focus on innovation, such as AI-assisted diagnostics and comprehensive care pathways, strengthens its competitive position globally.

Traumatic Brain Injuries Assessment Industry News:

• In June 2025, Abbott announced the launch of its laboratory-based blood test for evaluating mild traumatic brain injury, including concussions, which ran on its Alinity i and Architect i1000SR laboratory instruments. This development is expected to support the market by expanding access to standardized, scalable biomarker-based testing, improving diagnostic efficiency in hospitals and laboratories, and reducing reliance on imaging-only diagnostic pathways.
  
• In May 2024, bioMérieux announced that it had received U.S. FDA 510(k) clearance for VIDAS TBI (GFAP, UCH-L1), a serum-based test designed to support the assessment of patients with mild traumatic brain injury, including concussion. This development supported the market by enabling faster, objective, and less invasive diagnosis while helping reduce unnecessary CT scans, lowering healthcare costs, and improving emergency department workflow efficiency.
  
• In February 2024, Philips and SyntheticMR announced the launch of Smart Quant Neuro 3D, representing a major advancement in objective decision support for the diagnosis and therapy assessment of brain disorders such as multiple sclerosis, traumatic brain injury, and dementia. This development strengthened the market by enhancing quantitative brain imaging, improving diagnostic accuracy, and enabling more standardized and data-driven clinical decision-making.
  

The traumatic brain injuries assessment market research report includes an in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million from 2022 – 2035 for the following segments:

Click here to Buy Section of this Report

Market, By Product

• Screening devices
  • Computerized tomography (CT) scan
  • Magnetic resonance imaging (MRI)
  • Other screening devices 
• Monitoring devices
  • Intracranial pressure (ICP) monitoring
  • Partial pressure of oxygen in brain tissue (pBrO2)

Market, By End Use

• Hospitals
• Diagnostic centers
• Other end use

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada 
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE